|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
|
|---|---|---|---|---|---|
| Current assets: | |||||
| Cash | |||||
| Prepaid expense | |||||
| Prepaid insurance, current portion | |||||
| Total Current Assets | |||||
| Prepaid insurance, net of current portion | |||||
| Marketable securities held in Trust Account | |||||
| Deferred offering costs | |||||
| Total Assets | |||||
| Current Liabilities: | |||||
| Accrued expenses | |||||
| Accounts payable | |||||
| Accounts payable and accrued expenses | |||||
| Accrued offering cost | |||||
| Promissory note – related party | |||||
| Total Current Liabilities | |||||
| Deferred underwriting fee payable | |||||
| Total Liabilities | |||||
| Ordinary shares subject to possible redemption, 11,500,000 shares at a redemption value of $10.38 and $10.20 per share at June 30, 2026 and December 31, 2025, respectively | |||||
| Shareholders’ Deficit: | |||||
| Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 3,255,000 shares issued and outstanding at June 30, 2026 and December 31, 2025 | |||||
| Additional paid-in capital | |||||
| Accumulated deficit | |||||
| Total Shareholders’ Deficit | |||||
| Total Liabilities and Shareholders’ Deficit |
Loading...
